Ignite Creation Date:
2024-05-06 @ 10:01 AM
Last Modification Date:
2024-10-26 @ 12:23 PM
Study NCT ID:
NCT03130582
Status:
COMPLETED
Last Update Posted:
2017-04-28
First Post:
2017-04-22
Brief Title:
High-dose Etoposide Could Discriminate Patients With RefractoryRelapsed Lymphoma Benefit From APBSCT
Sponsor:
Yang Jun
Organization:
Shanghai General Hospital Shanghai Jiao Tong University School of Medicine
Organization Data
Organization:
Shanghai General Hospital Shanghai Jiao Tong University School of Medicine
Class:
OTHER
Study ID:
2015KY143
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Yang Jun
Lead Sponsor Class:
OTHER
Responsible Party:
Yang Jun
Responsible Party Title:
Principal Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Shanghai General Hospital Shanghai Jiao Tong University School of Medicine
Old Name:
None
Old Organization:
None